Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial

por Findling, Robert L., Landbloom, Ronald L., Mackle, Mary, Wu, Xiao, Snow-Adami, Linda, Chang, Kiki, Durgam, Suresh
Publicado 2016